Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
60.7M
-
Shares change
-
+1.82M
-
Total reported value, excl. options
-
$8.37B
-
Value change
-
+$250M
-
Put/Call ratio
-
0.95
-
Number of buys
-
157
-
Number of sells
-
-109
-
Price
-
$137.81
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q4 2021
325 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q4 2021.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.7M shares
.
Largest 10 shareholders include Capital World Investors (6.18M shares), Capital International Investors (5.01M shares), BlackRock Inc. (4.64M shares), STIFEL FINANCIAL CORP (3.05M shares), MARSHALL WACE, LLP (2.8M shares), ORACLE INVESTMENT MANAGEMENT INC (2.08M shares), STATE STREET CORP (1.65M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.64M shares), Allspring Global Investments Holdings, LLC (1.54M shares), and FMR LLC (1.51M shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.